Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Samsung Bioepis Builds Its Biosimilars Name In Europe

28 Aug 2017

• By Jung Won Shin

vialandmultiplesyringes_1200x675

Related Content

EU CHMP OKs Imraldi, Samsung Bioepis’ Biosimilar Of AbbVie’s Humira

26 Jun 2017

US Approvals Roundup: Cyltezo Biosimilar, Victoza CV Benefit, Gocovri In PD, Kedrab Rabies Biologic, Gout Combo Duzallo

28 Aug 2017

Remicade: Biosimilars And Pricing Pressure Wear On J&J's Blockbuster Brand

18 Jul 2017

Amgen's Amjevita Approved As First Biosimilar To AbbVie's Humira

24 Sep 2016

Exclusive Remicade Contracts Are Slowing Biosimilar Uptake

01 Aug 2017

Related Companies

Samsung Bioepis Co., Ltd.

AbbVie Inc.

Biogen, Inc.

Amgen, Inc.

Boehringer Ingelheim GmbH

Novartis AG

Additional Topics

Biosimilars Approvals Companies Launches Market Intelligence Regulation BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.